H.Res. 946 — Introduced in House

IV 117th CONGRESS 2d Session H. RES. 946 IN THE HOUSE OF REPRESENTATIVES February 25, 2022Mrs. Trahan (for herself, Mr. Welch, Mr. Trone, Ms. Sewell, Mr. Carter of Georgia, Mr. Fitzpatrick, Mr. Bacon, Mr. Moulton, Mr. Rush, and Ms. Lois Frankel of Florida) submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Supporting women’s cardiovascular health. Whereas cardiovascular disease is the leading cause of death for women in the United States; Whereas women with cardiovascular disease are often underdiagnosed or misdiagnosed; Whereas women are underrepresented in clinical trials which assess unique benefits and risks of new cardiovascular treatments; Whereas women of color are particularly underrepresented in clinical trials of new cardiovascular treatments; Whereas addressing known barriers to clinical trial participation will increase the number of women participating in clinical trials; Whereas there is a critical need for increased participation in cardiovascular intervention clinical trials by women; and Whereas there exists a lack of awareness about treatment options for women, including technologies to enable heart recovery or heart muscle recovery, which enables a superior quality of life following a heart event: Now, therefore, be it That the House of Representatives— (1) supports efforts to increase participation of women in cardiovascular intervention clinical trials; (2) recognizes the critical importance of education and awareness of advanced cardiovascular treatment options for women; and (3) encourages health care providers, drug and device manufacturers, and patient advocates to collaborate on ways to improve cardiovascular health among women.